Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G antigen 12E (GAGE12E) is a small protein consisting of 117 amino acids and is a member of the GAGE family of cancer/testis antigens[1]. These proteins are typically not expressed in most normal adult tissues but can be found at high levels in various tumors, such as melanoma, lung, and other cancers[5]. GAGE proteins are considered promising immunotherapy targets due to their restricted expression and immunogenicity, although their precise cellular function remains unclear. GAGE12E may contribute to cancer cell survival or evasion of immune recognition, but definitive mechanistic roles have not been fully established. No drugs are known to directly target GAGE12E, but its tumor-restricted expression supports its use as a potential cancer biomarker or target for T cell-based therapies[5][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G antigen 12E (GAGE12E).